Genitourinary syndrome of menopause (GSM) includes not only genital and sexual symptoms but also urinary symptoms. It may have a profound negative impact on the quality of life of postmenopausal women. This article discusses the importance of comprehension of GSM and the necessity of active treatment of this syndrome in postmenopausal women.
The new term genitourinary syndrome of menopause was introduced by the International Society for the Study of Women's Sexual Health and the North American Menopause Society in the year 2014. This term encompasses all the atrophic symptoms women may have in the vulvovaginal and bladder-urethral areas from loss of estrogen that occurs with menopause. Prevalence of GSM Vulvovaginal symptoms and sexual dysfunction In recent large cohort surveys in Western populations, 45% to 63% of postmenopausal women reported that they had experienced vulvovaginal…
